From the Wires
Therapeutic Solutions International Completes All SEC Filings and Becomes Fully Reporting
Company to Launch Migran-X(TM) and AMPSA CS(TM) Globally to Prevent Migraine Pain
By: Marketwired .
Dec. 3, 2012 08:45 AM
OCEANSIDE, CA -- (Marketwire) -- 12/03/12 -- Therapeutic Solutions International, Inc. (OTCQB: TSOI), announced today that it has recently completed all of its regulatory filings required by the Securities and Exchange Commission, and that it is now 'fully reporting' and compliant.
Tim Dixon, CEO of Therapeutic Solutions International, Inc., stated, "We are elated to have achieved this milestone for the company. As a result, TSI has been upgraded to a higher tier on OTCMarkets.com, (the "OTCQB Market Tier"), hence allowing investors access to timely information and liquidity.
In addition, we are very excited to begin the international launch of our key products Migran-X and AMPSA CS globally. We will be updating the investment community frequently over the weeks ahead with our anticipated progress."
Therapeutic Solutions International is a global manufacturer of the chairside anterior midpoint stop appliance (AMPSA) devices marketed internationally under the trade names Migran-X and AMPSA CS, which has helped countless patients prevent debilitating migraine and tension headache pain, bruxism, clenching, grinding, and TMJ disorders. The Migran-X and AMPSA CS devices are the most effective non-drug FDA cleared method of migraine prevention on the market today. The AMPSA is a device that a dentist fits on a patient for the treatment of medically diagnosed migraine pain, as well as migraine associated tension-type headaches, by reducing their signs and symptoms through the reduction of trigeminally innervated muscular activity, and for the prevention of bruxism and TMJ syndrome through the reduction of trigeminally innervated muscular activity.
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International, Inc. produces and markets the FDA cleared NTI Tension Suppression System devices sold in the United States under the tradename NTI-tss®, and internationally as the Migran-X and AMPSA CS for the prevention of medically diagnosed migraine pain. The device is the most cost effective, non-drug method of migraine prevention on the market today. We also license laboratories to manufacture and sell semi-custom AMPSA devices internationally. Our corporate website is www.therapeuticsolutionsint.com.
Safe Harbor Statement
Latest Cloud Developer Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week